Home/Filings/4/0001131096-19-000045
4//SEC Filing

Hull Brandon H 4

Accession 0001131096-19-000045

CIK 0001131096other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 8:13 PM ET

Size

14.8 KB

Accession

0001131096-19-000045

Insider Transaction Report

Form 4
Period: 2019-02-11
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-02-11$5.75/sh3,923$22,5570 total
    Exercise: $129.25From: 2016-06-01Exp: 2025-03-02Common Stock (3,923 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-02-11$43.85/sh4,036$176,9790 total
    Exercise: $91.15From: 2013-06-01Exp: 2022-08-01Common Stock (4,036 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-02-11$78.97/sh3,406$268,9720 total
    Exercise: $56.03From: 2012-07-01Exp: 2021-10-03Common Stock (3,406 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2019-02-11$108.09/sh4,200$453,9780 total
    Exercise: $26.91From: 2011-06-01Exp: 2020-08-02Common Stock (4,200 underlying)
  • Disposition to Issuer

    Common Stock

    2019-02-11$135.00/sh7,161$966,7350 total
Footnotes (4)
  • [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes.
  • [F2]1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration.
  • [F3]Represents shares of Common Stock underlying a non-qualified stock option ("Option") award with an exercise price less than $135. Pursuant to the Merger Agreement, on February 11, 2019,each vested or unvested in-the-money Option outstanding immediately prior to the Effective Time was canceled and the underlying shares converted into the right to receive the Merger Consideration (net of the Option exercise price, as described in the Merger Agreement).
  • [F4]The price reflected in this column is the cash payment amount per Option (representing the difference between the Merger Consideration and the Option exercise price).

Issuer

ATHENAHEALTH INC

CIK 0001131096

Entity typeother

Related Parties

1
  • filerCIK 0001357695

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:13 PM ET
Size
14.8 KB